177Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Biotherapy and Radiopharmaceuticals

• Publication date

  2008-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1089/cbr.2007.374PMID 18454689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints

  2006cited by this paper
• Preparation and preliminary biological evaluation of a 177Lu labeled nitroimidazole derivative for possible use in targeted tumor therapy

  2006cited by this paper
• Biodistribution of Radioiodinated Adenovirus Fiber Protein Knob Domain after Intravenous Injection in Mice

  2004cited by this paper
• Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.

  2004cited by this paper
• 153Sm-EDTMP for bone pain palliation in skeletal metastases

  2004cited by this paper
• Production logistics of 177Lu for radionuclide therapy.

  2003cited by this paper
• Bisphosphonates and radiation therapy for palliation of metastatic bone disease.

  2003cited by this paper
• Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

  2003cited by this paper
• 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation

  2002cited by this paper
• Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.

  2001cited by this paper
• Recent advances in radionuclide therapy.

  2001cited by this paper
• Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models.

  2001cited by this paper
• Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.

  2001cited by this paper
• Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.

  2001cited by this paper
• Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.

  2000cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Pain from Metastatic Bone Tumors

  1999cited by this paper
• Therapeutic radiopharmaceuticals.

  1999cited by this paper
• Reactor-produced radioisotopes from ORNL for bone pain palliation.

  1998cited by this paper
• 177Lu-EDTMP: a potential therapeutic bone agent.

  1998cited by this paper
• Table of isotopes, 8th edn

  1998cited by this paper
• Dosage and response in radiopharmaceutical therapy of painful osseous metastases.

  1996cited by this paper
• Cancer therapy using bone-seeking isotopes.

  1996cited by this paper
• Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.

  1996cited by this paper
• Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

  1995cited by this paper
• Radiotherapy for bone pain.

  1995cited by this paper
• Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.

  1994cited by this paper
• Radiotherapy for Bone Pain

  1994cited by this paper
• Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary report.

  1992cited by this paper
• Calculation of radiation dose at a bone-to-marrow interface using Monte Carlo modeling techniques (EGS4)

  1992cited by this paper
• Radiopharmaceuticals for palliation of metastatic osseous lesions: biologic and physical background.

  1992cited by this paper
• Bone seeking radiopharmaceuticals

  1990cited by this paper
• Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.

  1990cited by this paper
• Correlations between uptake of technetium, calcium, phosphate, and mineralization in rat tibial bone repair.

  1990cited by this paper
• Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.

  1989cited by this paper
• 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.

  1987cited by this paper
• Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.

  1987cited by this paper
• Treatment of metastatic bone pain with strontium-89.

  1987influential reference
• The prevalence and severity of pain in cancer

  1982cited by this paper
• Pain in far-advanced cancer

  1982cited by this paper
• Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.

  1980cited by this paper

• The radiological response of patients with advanced bone metastases to lutetium-177-labeled DOTA-ibandronic acid assessed by metabolic tumor volume

  2025cites this paper
• Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis

  2024cites this paper
• Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases

  2024cites this paper
• Efficacy and Safety of 177Lu-DOTA-IBA in Tumor Bone Metastasis Treatment

  2024cites this paper
• Safety and Efficacy of 68Ga- or 177Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases

  2023cites this paper
• The Role of Radiopharmaceuticals in the Bone Metastases Therapy

  2023cites this paper
• Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü

  2023cites this paper
• The dual and multifaceted role of relaxin-2 in cancer

  2023cites this paper
• Evaluation of photon, proton, and alpha interaction parameters of EDTMPLu and MDPLu medications used for some bone cancer

  2023cites this paper
• 177Lu-EDTMP radiation absorbed dose evaluation in man based on biodistribution data in Wistar rats

  2022cites this paper
• Bone marrow dosimetry for 141Ce-EDTMP as a potential bone pain palliation complex: A Monte Carlo study.

  2022cites this paper
• Relaxin inhibits 177Lu-EDTMP associated cell death in osteosarcoma cells through notch-1 pathway

  2022cites this paper
• Locoregional Radionuclide Cancer Therapy: Clinical and Scientific Aspects

  2021cites this paper
• Preclinical Imaging for Laboratory Rodents

  2021cites this paper
• Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity

  2021cites this paper
• Doping gadolinium versus lanthanum into hydroxyapatite particles for better biocompatibility in bone marrow stem cells.

  2021cites this paper
• An Impressive Approach in Nuclear Medicine: Theranostics.

  2021cites this paper
• Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases

  2021cites this paper
• Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases

  2021cites this paper
• FORMULATION AND QUALITY CONTROL STUDIES OF EDTMP FREEZE-DRIED KIT FOR THE PREPARATION OF 153 Sm-EDTMP

  2020influential citation
• Comparative studies on the potential use of 177Lu-based radiopharmaceuticals for the palliative therapy of bone metastases

  2020cites this paper
• TWO LABELED EDTMP RADIOPHARMACEUTICALS WITH Sm-153 AND Lu-177 FOR HUMAN BONE RADIOTHERAPY

  2020cites this paper
• Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain

  2020cites this paper
• Animal Cancer Therapy Models: Ready Translation to Humans

  2020cites this paper
• Labeling of ethylenediamine tetramethylene phosphonate with 153Sm and 177Lu,Comparison Study

  2020cites this paper
• Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions.

  2019cites this paper
• Ce-141-labeled DOTMP: A theranostic option in management of pain due to skeletal metastases.

  2019cites this paper
• Leveraging the power of non-radium radionuclide treatments in bone metastases.

  2019cites this paper
• 177Lu/153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone Metastases

  2019cites this paper
• Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications

  2019cites this paper
• 153Sm-EDTMP and 177Lu-EDTMP are equally safe and effective in pain palliation from skeletal metastases

  2018cites this paper
• Comparison of the efficacy of 177Lu-EDTMP, 177Lu-DOTMP and 188Re-HEDP towards bone osteosarcoma: an in vitro study

  2018cites this paper
• Highly Stable 177Lu-Organic Framework as a Potential Agent for Treatment of Metastatic Bone

  2018cites this paper
• Development of 177 lu-Based Agents for Targeted Radiotherapy : Laboratory to Clinics

  2018influential citation
• Radiolabeling, quality control, biodistribution, and imaging studies of 177 Lu-ibandronate.

  2018cites this paper
• Production, quality control, and biodistribution studies of 141Ce-EDTMP as a potential bone pain palliation agent

  2018cites this paper
• Pharmaceutical development, preclinical research and clinical application of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDP

  2017influential citation
• A "mix-and-use" approach for formulation of human clinical doses of 177 Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases.

  2017cites this paper
• Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170Tm-EDTMP prepared using in-house freeze-dried EDTMP kit.

  2017influential citation
• Pharmacokinetics in Intact Rats of N,N,N′,N′-Ethylenediaminetetrakis-(Methylenephosphonic Acid) Labeled with Gallium-68

  2017cites this paper
• Theranostic Applications of Lutetium-177 in Radionuclide Therapy.

  2016cites this paper
• Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex

  2016cites this paper
• Targeted Radionuclide Therapy for Bone Metastasis

  2016cites this paper
• Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC: A Proof-of-Principle Application.

  2016cites this paper
• Radium-223 dichloride in clinical practice: a review

  2016cites this paper
• Evaluation of ¹⁷⁷Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy.

  2016cites this paper
• Irradiation parameters play a crucial role in the (n, γ) production of 170Tm suitable for clinical use in bone pain palliation

  2016cites this paper
• Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases.

  2016cites this paper
• Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons

  2016cites this paper
• Reactor-Produced Therapeutic Radionuclides

  2016cites this paper
• Study of Bone Surface Absorbed Dose in Treatment of Bone Metastases via Selected Radiopharmaceuticals: Using MCNP4C Code and Available Experimental Data

  2015cites this paper
• Production, quality control, and bio-distribution studies of 159Gd-EDTMP as a palliative agent for bone pain

  2015cites this paper
• Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases

  2015cites this paper
• Production, quality control, biodistribution assessment and preliminary dose evaluation of [177Lu]-tetra phenyl porphyrin complex as a possible therapeutic agent

  2015cites this paper
• Metastatic Bone Pain Palliation using 177Lu-Ethylenediaminetetramethylene Phosphonic Acid

  2015cites this paper
• Production of 177Lu for Targeted Radionuclide Therapy: Available Options

  2015cites this paper
• Formulation and evaluation of freeze-dried DOTMP kit for the preparation of clinical-scale 177Lu-DOTMP and 153Sm-DOTMP at the hospital radiopharmacy

  2015cites this paper
• Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.

  2015cites this paper
• Thulium-170-Labeled Microparticles for Local Radiotherapy: Preliminary Studies

  2014cites this paper
• 177Lu-EDTMP for Treatment of Bone Pain in Patients with Disseminated Skeletal Metastases

  2014cites this paper
• On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux research reactor: the Indian experience

  2014cites this paper
• Erbium-169 labeled hydroxyapatite particulates for use in radiation synovectomy of digital joints – a preliminary investigation

  2014cites this paper
• 177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study

  2014cites this paper
• Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.

  2014cites this paper
• Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent

  2014cites this paper
• Formulation, Preclinical Evaluation, and Preliminary Clinical Investigation of an In-House Freeze-Dried EDTMP Kit Suitable for the Preparation of 177Lu-EDTMP

  2014influential citation
• Production, quality control and biodistribution studies of thulium-170-labeled ethylenediamine (tetramethylene phosphonic acid)

  2013cites this paper
• Radiolabeling, Stability Studies, and Pharmacokinetic Evaluation of Thulium-170-Labeled Acyclic and Cyclic Polyaminopolyphosphonic Acids

  2013cites this paper
• Naturally occurring canine osteosarcoma in the dog animal model for research of targeted radiotherapy using beta-emitting radioisotopes with various ligands

  2013cites this paper
• Production, quality control and pharmacokinetic studies of 177Lu–zoledronate for bone pain palliation therapy

  2013cites this paper
• Practicality of Production of 32P by Direct Neutron Activation for Its Utilization in Bone Pain Palliation as Na3[32P]PO4

  2013cites this paper
• Targeted radionuclide therapy--an overview.

  2013cites this paper
• Cellular toxicity and apoptosis studies in osteocarcinoma cells, a comparison of 177Lu-EDTMP and Lu-EDTMP.

  2013cites this paper
• Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer: A Phase II Study

  2013cites this paper
• Emergence and present status of Lu-177 in targeted radiotherapy: the Indian scenario

  2012cites this paper
• Use of nuclear medicine and imaging techniques in disorders of the bone system

  2012cites this paper
• The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.

  2012cites this paper
• An electro-amalgamation approach to produce 175Yb suitable for radiopharmaceutical applications

  2012cites this paper
• Empleo de la medicina nuclear y las técnicas de imágenes en las afecciones del sistema óseo

  2012cites this paper
• Timing and optimized acquisition parameters for the whole-body imaging of 177Lu-EDTMP toward performing bone pain palliation treatment

  2012cites this paper
• Production, Quality Control and Pharmacokinetic Studies of 177Lu-EDTMP for Human Bone Pain Palliation Therapy Trials

  2012cites this paper
• Szent István University Postgraduate School of Veterinary Science Biological evaluation of new beta-emitting radiopharmaceuticals for therapy of malignant and chronic diseases

  2011cites this paper
• Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.

  2011cites this paper
• Preparation and quality control of lutetium-177 bleomycin as a possible therapeutic agent

  2010cites this paper
• Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.

  2010cites this paper
• Radiometal complexes in molecular imaging and therapy.

  2010cites this paper
• Preparation and quality control of ¹⁷⁷Lu-[tris(1,10-phenanthroline) lutetium(III)] complex for therapy.

  2010cites this paper
• BASED RADIOPHARMACEUTICALS IN INDIA

  2010cites this paper
• (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.

  2009cites this paper